Richard Beckman is Chief Medical Officer of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 39,061 shares of ADVM, which is worth approximately $185,149. The most recent transaction as insider was on Sep 19, 2022, when has been sold 4,272 shares (Common Stock) at a price of $1.07 per share, resulting in proceeds of $4,571. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1K
0% 3M change
0% 12M change
Total Value Held $185,149

Richard Beckman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 19 2022
SELL
Open market or private sale
$4,571 $1.07 p/Share
4,272 Reduced 9.86%
39,061 Common Stock
Sep 14 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 41.67%
35,000 Common Stock
May 17 2022
BUY
Open market or private purchase
$8,200 $0.82 p/Share
10,000 Added 50.0%
10,000 Common Stock
RB

Richard Beckman

Chief Medical Officer
Redwood City, CA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM